JP2017522908A5 - - Google Patents

Download PDF

Info

Publication number
JP2017522908A5
JP2017522908A5 JP2017525327A JP2017525327A JP2017522908A5 JP 2017522908 A5 JP2017522908 A5 JP 2017522908A5 JP 2017525327 A JP2017525327 A JP 2017525327A JP 2017525327 A JP2017525327 A JP 2017525327A JP 2017522908 A5 JP2017522908 A5 JP 2017522908A5
Authority
JP
Japan
Prior art keywords
cfdna
determining
function
fragments
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017525327A
Other languages
English (en)
Other versions
JP2017522908A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/042310 external-priority patent/WO2016015058A2/en
Publication of JP2017522908A publication Critical patent/JP2017522908A/ja
Publication of JP2017522908A5 publication Critical patent/JP2017522908A5/ja
Pending legal-status Critical Current

Links

Claims (1)

  1. 対象者における疾患又は異常を識別する方法であって、
    当該対象者からの生物学的サンプルからセルフリーDNA(cfDNA)を単離する工程であって、当該単離cfDNAが複数のcfDNAフラグメントを含む、前記工程;
    当該複数のcfDNAフラグメントの少なくとも一部分に付随する配列を決定する工程;
    当該複数のcfDNAフラグメントの少なくともいくつかのcfDNAフラグメント末端に対する参照ゲノム内のゲノム上の場所を当該cfDNAフラグメント配列の関数として決定する工程;
    当該cfDNAを生じる組織及び/又は細胞タイプの少なくともいくつかを、当該cfDNAフラグメント末端の少なくともいくつかのゲノム上の場所の関数として決定する工程;及び
    当該疾患又は異常を、当該cfDNAを生じると決定された組織及び/又は細胞タイプの関数と認定する工程を含む、
    前記方法。
JP2017525327A 2014-07-25 2015-07-27 セルフリーdnaを生じる組織及び/又は細胞タイプを決定する方法、並びにそれを用いて疾患又は異常を識別する方法 Pending JP2017522908A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462029178P 2014-07-25 2014-07-25
US62/029,178 2014-07-25
US201462087619P 2014-12-04 2014-12-04
US62/087,619 2014-12-04
PCT/US2015/042310 WO2016015058A2 (en) 2014-07-25 2015-07-27 Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020203304A Division JP2021045161A (ja) 2014-07-25 2020-12-08 セルフリーdnaを生じる組織及び/又は細胞タイプを決定する方法、並びにそれを用いて疾患又は異常を識別する方法

Publications (2)

Publication Number Publication Date
JP2017522908A JP2017522908A (ja) 2017-08-17
JP2017522908A5 true JP2017522908A5 (ja) 2018-09-06

Family

ID=55163988

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017525327A Pending JP2017522908A (ja) 2014-07-25 2015-07-27 セルフリーdnaを生じる組織及び/又は細胞タイプを決定する方法、並びにそれを用いて疾患又は異常を識別する方法
JP2020203304A Pending JP2021045161A (ja) 2014-07-25 2020-12-08 セルフリーdnaを生じる組織及び/又は細胞タイプを決定する方法、並びにそれを用いて疾患又は異常を識別する方法
JP2023082794A Pending JP2023123420A (ja) 2014-07-25 2023-05-19 セルフリーdnaを生じる組織及び/又は細胞タイプを決定する方法、並びにそれを用いて疾患又は異常を識別する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020203304A Pending JP2021045161A (ja) 2014-07-25 2020-12-08 セルフリーdnaを生じる組織及び/又は細胞タイプを決定する方法、並びにそれを用いて疾患又は異常を識別する方法
JP2023082794A Pending JP2023123420A (ja) 2014-07-25 2023-05-19 セルフリーdnaを生じる組織及び/又は細胞タイプを決定する方法、並びにそれを用いて疾患又は異常を識別する方法

Country Status (8)

Country Link
US (4) US20170211143A1 (ja)
EP (2) EP4358097A1 (ja)
JP (3) JP2017522908A (ja)
KR (2) KR20220127359A (ja)
CN (2) CN117402950A (ja)
AU (1) AU2015292311B2 (ja)
CA (1) CA2956208A1 (ja)
WO (1) WO2016015058A2 (ja)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012129363A2 (en) 2011-03-24 2012-09-27 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US11261494B2 (en) 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
EP4036247B1 (en) 2012-09-04 2024-04-10 Guardant Health, Inc. Methods to detect rare mutations and copy number variation
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
ES2660989T3 (es) 2013-12-28 2018-03-27 Guardant Health, Inc. Métodos y sistemas para detectar variantes genéticas
TWI758011B (zh) 2014-07-18 2022-03-11 香港中文大學 Dna混合物中之組織甲基化模式分析
US20170211143A1 (en) 2014-07-25 2017-07-27 University Of Washington Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
WO2016123698A1 (en) * 2015-02-06 2016-08-11 Uti Limited Partnership Diagnostic assay for post-transplant assessment of potential rejection of donor organs
WO2016127944A1 (en) 2015-02-10 2016-08-18 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
WO2017012592A1 (en) 2015-07-23 2017-01-26 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free dna
EP3390668A4 (en) 2015-12-17 2020-04-01 Guardant Health, Inc. METHODS OF DETERMINING THE NUMBER OF TUMOR GENE COPIES BY ACELLULAR DNA ANALYSIS
US11514289B1 (en) * 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
WO2018009723A1 (en) * 2016-07-06 2018-01-11 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids
WO2018013837A1 (en) 2016-07-15 2018-01-18 The Regents Of The University Of California Methods of producing nucleic acid libraries
EP3494234A4 (en) * 2016-08-05 2020-03-04 The Broad Institute, Inc. METHOD FOR GENOM CHARACTERIZATION
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
US20200013482A1 (en) 2016-09-30 2020-01-09 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
US20200048711A1 (en) * 2016-10-12 2020-02-13 Bellwether Bio, Inc Determining cell type origin of circulating cell-free dna with molecular counting
WO2018072705A1 (en) 2016-10-19 2018-04-26 The Chinese University Of Hong Kong Gestational age assessment by methylation and size profiling of maternal plasma dna
MY195527A (en) 2016-10-24 2023-01-30 Grail Inc Methods And Systems For Tumor Detection
EP3548632A4 (en) 2016-11-30 2020-06-24 The Chinese University Of Hong Kong ANALYSIS OF CELLULAR DNA IN URINE AND OTHER SAMPLES
EP3555311B1 (en) * 2016-12-13 2024-06-26 Bellwether Bio, Inc. Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample
WO2018119452A2 (en) 2016-12-22 2018-06-28 Guardant Health, Inc. Methods and systems for analyzing nucleic acid molecules
CN110691792A (zh) 2017-01-10 2020-01-14 朱诺治疗学股份有限公司 细胞疗法的表观遗传学分析及相关方法
EP3574108A4 (en) 2017-01-25 2020-12-23 The Chinese University Of Hong Kong DIAGNOSTIC APPLICATIONS WITH THE USE OF NUCLEIC ACID FRAGMENTS
EP3635138B1 (en) 2017-05-15 2024-07-03 Katholieke Universiteit Leuven Method for analysing cell-free nucleic acids
EP3635133A4 (en) * 2017-06-09 2021-03-03 Bellwether Bio, Inc. DETERMINATION OF THE TYPE OF CANCER IN A SUBJECT BY PROBABILISTIC MODELING OF END POINTS OF CIRCULATING NUCLEIC ACID FRAGMENT
WO2018227211A1 (en) * 2017-06-09 2018-12-13 Bellwether Bio, Inc. Diagnosis of cancer or other physiological condition using circulating nucleic acid fragment sentinel endpoints
US10636512B2 (en) 2017-07-14 2020-04-28 Cofactor Genomics, Inc. Immuno-oncology applications using next generation sequencing
AU2018348249A1 (en) * 2017-10-12 2020-04-16 Nantomics, Llc Cancer score for assessment and response prediction from biological fluids
CN107545153B (zh) * 2017-10-25 2021-06-11 桂林电子科技大学 一种基于卷积神经网络的核小体分类预测方法
US20210317516A1 (en) * 2017-11-27 2021-10-14 Bgi Shenzhen Method for constructing library of cell-free dnas in body fluids and application thereof
CN108061794B (zh) * 2017-12-25 2020-03-27 苏州大学 一种无染色、无探针、无损检测细胞或类细胞结构微生物的类型及其周期的方法
CN111954720A (zh) 2018-01-12 2020-11-17 克拉雷特生物科学有限责任公司 用于分析核酸的方法和组合物
EP3765638A2 (en) * 2018-03-13 2021-01-20 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Diagnostic use of cell free dna chromatin immunoprecipitation
WO2019209884A1 (en) * 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
JP2021525069A (ja) 2018-05-18 2021-09-24 ザ ジョンズ ホプキンス ユニバーシティ 癌を査定および/または処置するためのセルフリーdna
WO2019236478A1 (en) * 2018-06-04 2019-12-12 Guardant Health, Inc. Methods and systems for determining the cellular origin of cell-free nucleic acids
KR20210016560A (ko) 2018-06-06 2021-02-16 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 핵산 라이브러리의 생성 방법 및 이를 실행하기 위한 조성물 및 키트
CN108796056A (zh) * 2018-06-28 2018-11-13 元码基因科技(北京)股份有限公司 基于游离dna的目标基因捕获技术进行组织溯源的方法
WO2020006369A1 (en) * 2018-06-29 2020-01-02 Guardant Health, Inc. Methods and systems for analysis of ctcf binding regions in cell-free dna
CN108913682A (zh) * 2018-07-05 2018-11-30 上海奥测医疗科技有限公司 一种制备cfDNA参考品的方法
KR20210039406A (ko) * 2018-07-23 2021-04-09 더 차이니즈 유니버시티 오브 홍콩 세포-프리 dna 손상 분석 및 이의 임상적 적용
CN109448783B (zh) * 2018-08-07 2022-05-13 清华大学 一种染色质拓扑结构域边界的分析方法
EP3856903A4 (en) 2018-09-27 2022-07-27 Grail, LLC METHYLATION MARKER AND TARGETED METHYLATION PROBE PANEL
WO2020076772A1 (en) * 2018-10-08 2020-04-16 Freenome Holdings, Inc. Transcription factor profiling
CN111172263A (zh) * 2018-11-12 2020-05-19 北京医院 一种应用于无创产前检测的参考物质及其制备方法
EP3884087A4 (en) * 2018-11-21 2022-09-07 Karius Inc. DETECTION AND PREDICTION OF INFECTIOUS DISEASES
US20200199685A1 (en) 2018-12-17 2020-06-25 Guardant Health, Inc. Determination of a physiological condition with nucleic acid fragment endpoints
JP2022514879A (ja) * 2018-12-19 2022-02-16 ザ チャイニーズ ユニバーシティ オブ ホンコン 無細胞dna末端特性
US11657897B2 (en) * 2018-12-31 2023-05-23 Nvidia Corporation Denoising ATAC-seq data with deep learning
CN112424372A (zh) * 2019-01-24 2021-02-26 Illumina公司 用于监测器官健康和疾病的方法和系统
WO2020160414A1 (en) 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
CN109841265B (zh) * 2019-02-22 2021-09-21 清华大学 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用
WO2020198942A1 (zh) * 2019-03-29 2020-10-08 中国科学技术大学 基于峰聚类的单细胞染色质可及性测序数据分析方法和系统
US11939636B2 (en) 2019-05-31 2024-03-26 Guardant Health, Inc. Methods and systems for improving patient monitoring after surgery
CN110272985B (zh) * 2019-06-26 2021-08-17 广州市雄基生物信息技术有限公司 基于外周血血浆游离dna高通量测序技术的肿瘤筛查试剂盒及其系统与方法
EP4041919A1 (en) 2019-09-30 2022-08-17 Guardant Health, Inc. Compositions and methods for analyzing cell-free dna in methylation partitioning assays
CN110739027B (zh) * 2019-10-23 2023-04-18 深圳吉因加医学检验实验室 一种基于染色质区域覆盖深度的癌症组织定位方法及系统
CA3157560A1 (en) 2019-11-26 2021-06-03 Dustin Howard HITE Methods, compositions and systems for improving the binding of methylated polynucleotides
CN115298324A (zh) * 2019-12-18 2022-11-04 香港中文大学 游离dna断裂和核酸酶
EP4077715A1 (en) * 2019-12-19 2022-10-26 Agency for Science, Technology and Research A method of estimating a circulating tumor dna burden and related kits and methods
WO2021130356A1 (en) 2019-12-24 2021-07-01 Vib Vzw Disease detection in liquid biopsies
AU2021205853A1 (en) * 2020-01-08 2023-11-23 Grail, Inc. Biterminal dna fragment types in cell-free samples and uses thereof
WO2021141220A1 (ko) * 2020-01-09 2021-07-15 서울대학교 산학협력단 ATAC-seq 데이터 정규화 및 이의 활용 방법
CN111254194B (zh) * 2020-01-13 2021-09-07 东南大学 基于cfDNA的测序及数据分析的癌症相关生物标记及其在cfDNA样品分类中的应用
EP4104179A1 (en) * 2020-02-13 2022-12-21 10X Genomics, Inc. Systems and methods for joint interactive visualization of gene expression and dna chromatin accessibility
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
EP4143338A1 (en) 2020-04-30 2023-03-08 Guardant Health, Inc. Methods for sequence determination using partitioned nucleic acids
CN111724860B (zh) * 2020-06-18 2021-03-16 深圳吉因加医学检验实验室 一种基于测序数据识别染色质开放区域的方法及装置
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
CN111881418B (zh) * 2020-07-27 2023-05-16 中国农业科学院农业信息研究所 一种基于二分法的大豆气象产量预测方法及系统
US11946044B2 (en) 2020-07-30 2024-04-02 Guardant Health, Inc. Methods for isolating cell-free DNA
CN112085067B (zh) * 2020-08-17 2022-07-12 浙江大学 一种高通量筛选dna损伤反应抑制剂的方法
JP2023540221A (ja) 2020-08-25 2023-09-22 ガーダント ヘルス, インコーポレイテッド バリアントの起源を予測するための方法およびシステム
US20230348997A1 (en) * 2020-09-17 2023-11-02 The Regents Of The University Of Colorado, A Body Corporate Signatures in cell-free dna to detect disease, track treatment response, and inform treatment decisions
JP2023544721A (ja) 2020-09-30 2023-10-25 ガーダント ヘルス, インコーポレイテッド 分配およびメチル化依存性ヌクレアーゼを使用してdnaを解析するための組成物および方法
US20220154286A1 (en) 2020-10-23 2022-05-19 Guardant Health, Inc. Compositions and methods for analyzing dna using partitioning and base conversion
WO2022115810A1 (en) 2020-11-30 2022-06-02 Guardant Health, Inc. Compositions and methods for enriching methylated polynucleotides
EP4267757A1 (en) 2020-12-23 2023-11-01 Guardant Health, Inc. Methods and systems for analyzing methylated polynucleotides
TW202242145A (zh) * 2020-12-29 2022-11-01 比利時商比利時意志有限公司 核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析
US20230175064A1 (en) * 2021-02-09 2023-06-08 Illumina, Inc. Methods and systems for monitoring organ health and disease
EP4291679A1 (en) 2021-02-12 2023-12-20 Guardant Health, Inc. Methods and compositions for detecting nucleic acid variants
JP2024511425A (ja) 2021-03-25 2024-03-13 ガーダント ヘルス, インコーポレイテッド 免疫細胞dnaを定量するための方法および組成物
WO2022216981A1 (en) * 2021-04-08 2022-10-13 Delfi Diagnostics, Inc. Method of detecting cancer using genome-wide cfdna fragmentation profiles
EP4320618A2 (en) * 2021-04-08 2024-02-14 Fred Hutchinson Cancer Center Cell-free dna sequence data analysis method to examine nucleosome protection and chromatin accessibility
EP4359562A1 (en) 2021-06-21 2024-05-01 Guardant Health, Inc. Methods and compositions for copy-number informed tissue-of-origin analysis
WO2023056065A1 (en) 2021-09-30 2023-04-06 Guardant Health, Inc. Compositions and methods for synthesis and use of probes targeting nucleic acid rearrangements
WO2023197004A1 (en) 2022-04-07 2023-10-12 Guardant Health, Inc. Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
GB202205710D0 (en) 2022-04-19 2022-06-01 Univ Of Essex Enterprises Limited Cell-free DNA-based methods
WO2024006908A1 (en) 2022-06-30 2024-01-04 Guardant Health, Inc. Enrichment of aberrantly methylated dna
WO2024056720A1 (en) 2022-09-13 2024-03-21 Medizinische Universität Graz Determining of health status and treatment monitoring with cell-free dna
WO2024073508A2 (en) 2022-09-27 2024-04-04 Guardant Health, Inc. Methods and compositions for quantifying immune cell dna

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0016742D0 (en) * 2000-07-10 2000-08-30 Simeg Limited Diagnostic method
JP2002272497A (ja) 2001-03-15 2002-09-24 Venture Link Co Ltd 癌の診断方法、およびその診断用ベクター
US6927028B2 (en) 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
WO2004078999A1 (en) 2003-03-05 2004-09-16 Genetic Technologies Limited Identification of fetal dna and fetal cell markers in maternal plasma or serum
ATE435301T1 (de) 2003-10-16 2009-07-15 Sequenom Inc Nicht invasiver nachweis fötaler genetischer merkmale
US20070122823A1 (en) 2005-09-01 2007-05-31 Bianchi Diana W Amniotic fluid cell-free fetal DNA fragment size pattern for prenatal diagnosis
ES2739483T3 (es) 2006-02-02 2020-01-31 Univ Leland Stanford Junior Detección genética fetal no invasiva mediante análisis digital
WO2007100911A2 (en) 2006-02-28 2007-09-07 University Of Louisville Research Foundation Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
TWI335354B (en) 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
US7842482B2 (en) 2007-02-26 2010-11-30 The Chinese University Of Hong Kong Methods and kits for diagnosis, prognosis or monitoring of Epstein-Barr virus (EBV)-associated cancer
US20100112590A1 (en) 2007-07-23 2010-05-06 The Chinese University Of Hong Kong Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment
PL2557520T3 (pl) 2007-07-23 2021-10-11 The Chinese University Of Hong Kong Określanie zaburzenia równowagi sekwencji kwasu nukleinowego
US20090053719A1 (en) 2007-08-03 2009-02-26 The Chinese University Of Hong Kong Analysis of nucleic acids by digital pcr
US8748100B2 (en) 2007-08-30 2014-06-10 The Chinese University Of Hong Kong Methods and kits for selectively amplifying, detecting or quantifying target DNA with specific end sequences
WO2009051842A2 (en) 2007-10-18 2009-04-23 The Johns Hopkins University Detection of cancer by measuring genomic copy number and strand length in cell-free dna
US20100041048A1 (en) 2008-07-31 2010-02-18 The Johns Hopkins University Circulating Mutant DNA to Assess Tumor Dynamics
US8476013B2 (en) * 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
PT2334812T (pt) 2008-09-20 2017-03-29 Univ Leland Stanford Junior ¿diagnóstico não invasivo de aneuploidia fetal por sequenciação
US8835110B2 (en) 2008-11-04 2014-09-16 The Johns Hopkins University DNA integrity assay (DIA) for cancer diagnostics, using confocal fluorescence spectroscopy
WO2010112316A1 (en) 2009-03-31 2010-10-07 Oridis Biomed Forschungs- Und Entwicklungs Gmbh Method for diagnosis of cancer and monitoring of cancer treatments
WO2011053790A2 (en) 2009-10-30 2011-05-05 Fluidigm Corporation Assay of closely linked targets in fetal diagnosis and coincidence detection assay for genetic analysis
HUE061110T2 (hu) 2009-11-05 2023-05-28 Univ Hong Kong Chinese Magzati genomelemzés anyai biológiai mintából
JP5770737B2 (ja) 2009-11-06 2015-08-26 ザ チャイニーズ ユニバーシティ オブ ホンコン サイズに基づくゲノム分析
WO2011090556A1 (en) 2010-01-19 2011-07-28 Verinata Health, Inc. Methods for determining fraction of fetal nucleic acid in maternal samples
US9260745B2 (en) 2010-01-19 2016-02-16 Verinata Health, Inc. Detecting and classifying copy number variation
WO2011103236A2 (en) * 2010-02-18 2011-08-25 The Johns Hopkins University Personalized tumor biomarkers
US20120053062A1 (en) * 2010-08-24 2012-03-01 Bio Dx, Inc. Defining diagnostic and therapeutic targets of conserved free floating fetal dna in maternal circulating blood
EP2426217A1 (en) 2010-09-03 2012-03-07 Centre National de la Recherche Scientifique (CNRS) Analytical methods for cell free nucleic acids and applications
CA2817370C (en) 2010-11-30 2022-02-01 The Chinese University Of Hong Kong Detection of genetic or molecular aberrations associated with cancer
CA3067612A1 (en) 2011-09-22 2013-03-28 Lineage Biosciences, Inc. Compositions and methods for analyzing heterogeneous samples
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP2771483A1 (en) 2011-10-25 2014-09-03 ONCOTYROL - Center for Personalized Cancer Medicine GmbH Method for diagnosing a disease based on plasma-dna distribution
US9757458B2 (en) 2011-12-05 2017-09-12 Immunomedics, Inc. Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells
SG11201505515XA (en) 2012-01-27 2015-09-29 Univ Leland Stanford Junior Methods for profiling and quantitating cell-free rna
EP4155401A1 (en) * 2012-03-02 2023-03-29 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
AU2013232123B2 (en) 2012-03-13 2014-10-30 The Chinese University Of Hong Kong Methods for analyzing massively parallel sequencing data for noninvasive prenatal diagnosis
ES2902401T3 (es) * 2012-05-21 2022-03-28 Sequenom Inc Métodos y procesos para la evaluación no invasiva de variaciones genéticas
WO2013177581A2 (en) * 2012-05-24 2013-11-28 University Of Washington Through Its Center For Commercialization Whole genome sequencing of a human fetus
US11261494B2 (en) * 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
EP4036247B1 (en) 2012-09-04 2024-04-10 Guardant Health, Inc. Methods to detect rare mutations and copy number variation
WO2014039729A1 (en) * 2012-09-05 2014-03-13 Stamatoyannopoulos John A Methods and compositions related to regulation of nucleic acids
NZ717423A (en) 2012-09-20 2017-08-25 Univ Hong Kong Chinese Non-invasive determination of methylome of fetus or tumor from plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
CN105555968B (zh) * 2013-05-24 2020-10-23 塞昆纳姆股份有限公司 遗传变异的非侵入性评估方法和过程
WO2014194113A2 (en) * 2013-05-29 2014-12-04 Chronix Biomedical Detection and quantification of donor cell-free dna in the circulation of organ transplant recipients
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
CN106460070B (zh) * 2014-04-21 2021-10-08 纳特拉公司 检测染色体片段中的突变和倍性
US10318704B2 (en) * 2014-05-30 2019-06-11 Verinata Health, Inc. Detecting fetal sub-chromosomal aneuploidies
TWI758011B (zh) 2014-07-18 2022-03-11 香港中文大學 Dna混合物中之組織甲基化模式分析
US20170211143A1 (en) 2014-07-25 2017-07-27 University Of Washington Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
US11242559B2 (en) 2015-01-13 2022-02-08 The Chinese University Of Hong Kong Method of nuclear DNA and mitochondrial DNA analysis
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
US10319463B2 (en) 2015-01-23 2019-06-11 The Chinese University Of Hong Kong Combined size- and count-based analysis of maternal plasma for detection of fetal subchromosomal aberrations
WO2016127944A1 (en) 2015-02-10 2016-08-18 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
WO2017012592A1 (en) 2015-07-23 2017-01-26 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free dna

Similar Documents

Publication Publication Date Title
JP2017522908A5 (ja)
JP2011520451A5 (ja)
WO2011143659A3 (en) Nucleic acid isolation methods
WO2016015058A3 (en) Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
HK1259309A1 (zh) 用於現場或基於云的dna和rna處理和分析的基因組學基礎架構
DK3348638T3 (da) Fremgangsmåde til at konvertere genomsekvens fra gram-positiv bakterie ved specifikt at konvertere nukleinsyrebase i tilsigtet dna-sekvens, og molekylkompleks anvendt dertil
JP2013005803A5 (ja)
EA201792663A1 (ru) Способы скрининга бактерий, архей, водорослей и дрожжей с использованием нуклеиновых кислот crispr
EP3626832A3 (en) Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
MX2016016713A (es) Procesos y sistemas para el montaje de secuencias de acido nucleico.
WO2016126871A3 (en) Sequencing of nucleic acids via barcoding in discrete entities
WO2015200717A3 (en) Pcr-activated sorting (pas)
WO2014116729A3 (en) Haplotying of hla loci with ultra-deep shotgun sequencing
WO2015119941A3 (en) Genome fractioning
JP2008245635A5 (ja)
WO2016109782A3 (en) Methods and compositions for detecting colorectal neoplasias
WO2016065349A3 (en) Short non-coding protein regulatory rnas (sprrnas) and methods of use
JP2011004745A5 (ja)
WO2016130572A3 (en) Methods of determining levels of exposure to radiation and uses thereof
WO2016109799A3 (en) Method of rna isolation from clinical samples
WO2013056087A3 (en) Compositions and methods for treating and preventing coronary heart disease
JP2021503610A5 (ja)
EP2708607A3 (en) Genetic markers for Myb28
WO2015112948A3 (en) Methods for determining a nucleotide sequence
EP3258264A4 (en) Method for quantifying biological material, pathological diagnosis support system and program